Document is current
Any future updates will be listed below
-
Authors
Gomez, Juan L.
Magnus, Christopher J. https://orcid.org/0000-0001-5640-0116
Bonaventura, Jordi https://orcid.org/0000-0002-4745-0151
Solis, Oscar https://orcid.org/0000-0002-8285-5891
Curry, Fallon P.
Levinstein, Marjorie R. https://orcid.org/0000-0003-4360-1503
Budinich, Reece C.
Carlton, Meghan L.
Ventriglia, Emilya N.
Lam, Sherry
Wang, Le
Schoenborn, Ingrid
Dunne, William https://orcid.org/0009-0007-1334-6069
Michaelides, Michael https://orcid.org/0000-0003-0398-4917
Sternson, Scott M. https://orcid.org/0000-0002-0835-444X
- License Information
-
More Information
Article History
Received: 13 May 2024
Accepted: 17 July 2025
First Online: 27 August 2025
Competing interests
: S.M.S. and C.J.M. have a pending patent application on this technology (US patent application 20240002463-A1) as well as additional issued patents on related chemogenetic technologies. S.M.S. is a consultant for Kriya Therapeutics, which is focused on therapeutic applications of chemogenetics. M.M. is a principal investigator on a cooperative research and development agreement between NIDA and Kriya Therapeutics. The other authors declare no competing interests.
